Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Bioanalytical Services

We develop, validate and apply assays for small and large molecules, generics, and biomarkers to provide essential exposure data for drug development. Our comprehensive services complement drug discovery and development needs from preclinical development through to market. Our work is provided on both a stand-alone basis and as part of an integrated service offering.

View the Bioanalytical Equipment and Capabilities List